scholarly article | Q13442814 |
P356 | DOI | 10.1212/WNL.57.6.1036 |
P698 | PubMed publication ID | 11571331 |
P2093 | author name string | Mayer SA | |
Bates JE | |||
Claassen J | |||
Emerson RG | |||
Hirsch LJ | |||
Thompson TB | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | midazolam | Q423071 |
status epilepticus | Q980709 | ||
P304 | page(s) | 1036-1042 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus | |
P478 | volume | 57 |
Q33736047 | Abnormal neuroimaging is associated with early in-hospital seizures in pediatric abusive head trauma |
Q41238856 | Acute brain failure in severe sepsis: a prospective study in the medical intensive care unit utilizing continuous EEG monitoring |
Q47694824 | Analysis of clinical characteristics and risk factors for mortality in human status epilepticus |
Q37623219 | Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. |
Q54967844 | Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model. |
Q44930389 | Burst suppression on amplitude-integrated electroencephalogram may be induced by midazolam: a report on three cases |
Q39036581 | Childhood dystonias |
Q26746873 | Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus |
Q30300886 | Consensus statement on continuous EEG in critically ill adults and children, part I: indications |
Q36178886 | Continuous electroencephalogram monitoring in critically ill patients |
Q36256091 | Continuous electroencephalogram monitoring in the critically ill. |
Q34929469 | Continuous electroencephalographic monitoring in neurocritical care |
Q33741490 | De novo generalized periodic discharges related to anesthetic withdrawal resolve spontaneously |
Q51303564 | Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting. |
Q37620184 | Dynamic regimes of neocortical activity linked to corticothalamic integrity correlate with outcomes in acute anoxic brain injury after cardiac arrest |
Q36523187 | Early Hypothermia for Refractory Status Epilepticus |
Q37913698 | Electroencephalography in clinical epilepsy research |
Q38248151 | Electrophysiologic monitoring in acute brain injury |
Q38599756 | Emergency Neurological Life Support: Status Epilepticus |
Q50075797 | Emergency Neurological Life Support: Status Epilepticus |
Q38041474 | Emergency neurological life support: status epilepticus |
Q38004984 | Guidelines for the evaluation and management of status epilepticus |
Q91901602 | Guiding Antiepileptic Therapy in a Pediatric Patient with Severe Meningoencephalitis and Decompressive Craniectomy with the Use of Amplitude-Integrated Electroencephalography |
Q37593258 | High-dose midazolam infusion for refractory status epilepticus |
Q48663156 | High-dose midazolam therapy for refractory status epilepticus in children |
Q46252806 | In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. |
Q34680713 | Is it status? |
Q33892365 | Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. |
Q46819272 | Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome |
Q26799109 | Ketamine for the treatment of refractory status epilepticus |
Q36404830 | Literature review, case report, and expert discussion of prolonged refractory status epilepticus |
Q27028089 | Management of refractory status epilepticus in adults: still more questions than answers |
Q34618163 | Management of status dystonicus: our experience and review of the literature |
Q35092368 | NMDA antagonists for refractory seizures. |
Q26745188 | Neurocritical care update |
Q99564405 | New-onset SUPER refractory status epilepticus: A case series of 26 patients |
Q36760656 | Non-convulsive status epilepticus in adults: clinical forms and treatment |
Q48313099 | Non-convulsive status epilepticus in the postanesthesia care unit following meningioma excision |
Q30544942 | Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomes |
Q44182121 | Nonconvulsive status epilepticus after subarachnoid hemorrhage |
Q37594859 | Nonconvulsive status epilepticus and coma |
Q48606337 | Nonconvulsive status epilepticus in a neurological intensive care unit: profile in a developing country |
Q38803784 | Nonconvulsive status epilepticus in adults - insights into the invisible. |
Q35018494 | Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting |
Q38970355 | Observed medical and surgical complications of prolonged barbiturate coma for refractory status epilepticus |
Q38289996 | Pathophysiology and Management of Moderate and Severe Traumatic Brain Injury in Children |
Q37867301 | Pharmacological management of seizures and status epilepticus in critically ill patients. |
Q48170445 | Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults. |
Q33444384 | Predictors of refractoriness in a Turkish status epilepticus data bank |
Q36226433 | Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation |
Q48504182 | Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage |
Q37049594 | Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons |
Q37000111 | Recent developments in the diagnosis and treatment of status epilepticus |
Q38105043 | Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. |
Q49075795 | Seizures and impairment of consciousness |
Q30448312 | Sixty day continuous use of subdermal wire electrodes for EEG monitoring during treatment of status epilepticus |
Q38439932 | Status epilepticus in adults |
Q37985377 | Status epilepticus: a review, with emphasis on refractory cases. |
Q46582164 | Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin |
Q41860120 | Status epilepticus: current treatment strategies |
Q48088538 | Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs): a common EEG phenomenon in the critically ill. |
Q34666494 | The current state of treatment of status epilepticus |
Q35475202 | The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists |
Q36625012 | The management of refractory status epilepticus: an update |
Q34902253 | The probability of seizures during EEG monitoring in critically ill adults |
Q85032482 | Treatment Options in the Management of Status Epilepticus |
Q34427751 | Treatment of Convulsive and Nonconvulsive Status Epilepticus |
Q26783899 | Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients |
Q89160827 | Treatment of Refractory and Super-refractory Status Epilepticus |
Q37019705 | Treatment of acute seizures and status epilepticus |
Q37822704 | Treatment of refractory status epilepticus in childhood. |
Q34570571 | Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review |
Q44454449 | Treatment of status epilepticus: a survey of neurologists |
Q54767431 | Usefulness of intravenous lacosamide in status epilepticus. |
Q37106001 | Which anesthetic should be used in the treatment of refractory status epilepticus? |
Q81086495 | [Status epilepticus] |
Search more.